MarketAxess Holdings Inc. MKTX
165.68 USD +0.20 (+0.12%)
At closeNov 3, 2026, 4:00 PM EST
165.68 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
165.29 Day range 165.73
108.75 52-week range 195.97
- YTD
- -8.59%
- 1 year
- +4.10%
Analyst view
Consensus: hold
Hold
Price target (mean) 162.22 -2.1% downside
Now 165.68
- Target (low)
- 124.00
- Target (mean)
- 162.22
- Target (high)
- 167.00
Ratings (0m) 12 0 buy · 12 hold · 0 sell
- Strong buy0
- Buy0
- Hold12
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.79 | 1.70 – 1.85 | 1.68 | +6.3% | 218.11M | +4.2% | 5 |
| Next quarter | 2.31 | 2.11 – 2.53 | 2.25 | +2.5% | 242.17M | +3.8% | 7 |
| Current year | 7.84 | 7.77 – 7.93 | 7.39 | +6.0% | 889.14M | +5.1% | 6 |
| Next year | 8.69 | 7.95 – 9.34 | 7.84 | +10.9% | 950.17M | +6.9% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 11, 2026 | Keefe, Bruyette & Woods | Downgrade | Outperform | Market Perform |
| Aug 10, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | UBS | Downgrade | Buy | Neutral |
| Jul 15, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 10, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | UBS | Maintained | Buy | Buy |
| Jun 30, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jun 12, 2026 | B of A Securities | Upgrade | Underperform | Neutral |
| Jun 11, 2026 | Rothschild & Co | Downgrade | Buy | Neutral |
| May 11, 2026 | UBS | Maintained | Buy | Buy |
| May 11, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 17, 2026 | Argus Research | Downgrade | Buy | Hold |
| Feb 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jan 15, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jan 14, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 9, 2026 | UBS | Maintained | Buy | Buy |
| Jan 8, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 22, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 17, 2025 | Argus Research | Maintained | Buy | Buy |
| Nov 20, 2025 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 10, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 10, 2025 | Keefe, Bruyette & Woods | Maintained | Market Perform | Market Perform |
| Oct 8, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 7, 2025 | UBS | Maintained | Buy | Buy |
| Oct 1, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 25, 2025 | Argus Research | Upgrade | Hold | Buy |
| Aug 11, 2025 | Jefferies | Maintained | Hold | Hold |
| Aug 7, 2025 | UBS | Maintained | Buy | Buy |